We are live on ! Find out more
MD icon

Pediatrix Medical

268 hedge funds and large institutions have $1.35B invested in Pediatrix Medical in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 102 increasing their positions, 95 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more call options, than puts

Call options by funds: $787K | Put options by funds: $444K

23% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 30

17% more capital invested

Capital invested by funds: $1.16B → $1.35B (+$193M)

2% more funds holding

Funds holding: 264268 (+4)

7% more repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 95

1.34% less ownership

Funds ownership: 93.88%92.54% (-1.3%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
268
Holders Change
+4
Holders Change %
+1.52%
% of All Funds
3.52%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
37
Increased
102
Reduced
95
Closed
30
Calls
$787K
Puts
$444K
Net Calls
+$343K
Net Calls Change
-$857K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$232M -$1.48M -98,843 -0.7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$182M -$1.38M -92,357 -0.8%
Victory Capital Management
3
Victory Capital Management
Texas
$69.1M +$14.5M +968,553 +31%
State Street
4
State Street
Massachusetts
$59.1M +$618K +41,255 +1%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$56.9M +$1.22M +81,554 +2%
American Century Companies
6
American Century Companies
Missouri
$44.9M +$11.3M +751,109 +39%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$36.9M -$3.14M -209,500 -9%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$36.3M +$2.52M +168,461 +8%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$33.9M +$6.65M +443,575 +28%
N
10
Nuveen
North Carolina
$26M +$10.7M +711,696 +85%
Charles Schwab
11
Charles Schwab
California
$24.2M +$2.69M +179,297 +14%
Boston Partners
12
Boston Partners
Massachusetts
$24.1M +$125K +8,335 +0.6%
Renaissance Technologies
13
Renaissance Technologies
New York
$21.9M +$1.53M +102,100 +8%
Morgan Stanley
14
Morgan Stanley
New York
$21.4M -$554K -36,951 -3%
Qube Research & Technologies (QRT)
15
Qube Research & Technologies (QRT)
United Kingdom
$19.2M +$6.11M +407,780 +55%
Northern Trust
16
Northern Trust
Illinois
$15.6M +$342K +22,828 +3%
Invesco
17
Invesco
Georgia
$14.7M +$4.24M +282,840 +48%
AllianceBernstein
18
AllianceBernstein
Tennessee
$14.1M -$15M -998,947 -54%
JP Morgan Chase
19
JP Morgan Chase
New York
$13.9M +$2.11M +140,577 +20%
DIA
20
Dana Investment Advisors
Wisconsin
$13.4M +$632K +42,162 +6%
Goldman Sachs
21
Goldman Sachs
New York
$12.8M -$360K -23,988 -3%
CM
22
CastleKnight Management
New York
$11.4M -$363K -24,250 -3%
Ameriprise
23
Ameriprise
Minnesota
$11.3M -$1.09M -72,724 -10%
BCM
24
Bridgeway Capital Management
Texas
$10.8M +$1.08M +71,907 +13%
BIP
25
Brandes Investment Partners
California
$10.6M +$982K +65,499 +12%

MD Hedge Fund Activity: Q3 2025 in Review

268 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2025, worth a combined $1.35B — up 17% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new MD positions and 30 closed out — a net gain of 7 holders — while 102 added to existing stakes and 95 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $14.5M. The largest seller was AllianceBernstein, cutting an estimated $15M.

  • 268 institutional investors held Pediatrix Medical (MD) as of Q3 2025, up from 264 in Q2 2025.
  • Funds reported $1.35B of Pediatrix Medical stock for Q3 2025, up 17% quarter-over-quarter.
  • 37 funds opened new Pediatrix Medical positions in Q3 2025 and 30 closed out, a net change of +7 holders.
  • The largest Pediatrix Medical buyer in Q3 2025 was Victory Capital Management, an estimated $14.5M added.
  • The largest Pediatrix Medical seller in Q3 2025 was AllianceBernstein, an estimated $15M sold.

Based on aggregated 13F filings for Q3 2025.